Demographic and Baseline Disease Characteristics of SynAIRgy: A Phase 3 Trial of Aroxybutynin and Atomoxetine (AD109) in Obstructive Sleep Apnea

Sleep Medicine 2026

View at publisher

Authors: P J Strollo, John Cronin, Huy Pho, Luigi Taranto‐Montemurro, R. Farkas

DOI: 10.1016/j.sleep.2025.108009

Cited by: 0

Fields of Study & Subjects

Obstructive Sleep Apnea Research Sleep and related disorders Chronic Obstructive Pulmonary Disease (COPD) Research